These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 498294)

  • 21. [On the standardization of FDP assays (author's transl)].
    Ikematsu S; Matsubara Y; Konishi S
    Rinsho Byori; 1976 Apr; 24(4):329-33. PubMed ID: 945388
    [No Abstract]   [Full Text] [Related]  

  • 22. [The detection of soluble fibrin complexes by a haemagglutination test. Clinical applications (author's transl)].
    Soria J; Soria C; de Rodriguez S; Horellou MH; Samama M; Bilski-Pasquier G
    Nouv Presse Med; 1977 Dec; 6(43):4045-8. PubMed ID: 600751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunological assay and radioimmunoassay of FDP on human serum (author's transl)].
    Abe K
    Rinsho Byori; 1978; 26(4):313-21. PubMed ID: 671777
    [No Abstract]   [Full Text] [Related]  

  • 24. [The radioimmunological assay of fibrinogen breakdown products with E antigen during postoperative venous thromboses. Study in 46 cases of arthroplasty for osteoarthrosis of the hip (author's transl)].
    Dechavanne M; Ville D; Clermont N; Pouillaude JM; Clermont A; Viala JJ; de Mourgues G
    Nouv Presse Med; 1977 Nov; 6(40):3721-4. PubMed ID: 604924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relation between fibrin/fibrinogen degradation products in malignant fluids and the fibrinolytic activity of the peritoneum].
    Takahashi M; Yoshida K; Kano K; Machida T; Nakamura Y; Miura Y; Miura N; Kanno S
    Gan No Rinsho; 1986 Dec; 32(15):1945-9. PubMed ID: 3806965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of the fibrin degradation products in the synovial fluid of rheumatological diseases (author's transl)].
    Kolodie L; Phelipp X; Baccard C
    Sem Hop; 1980 May 8-15; 56(17-18):832-6. PubMed ID: 6248965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Blood coagulation analysis using laser nephelometry (author's transl)].
    Suenaga R
    Rinsho Byori; 1979 Sep; 27(9):766-73. PubMed ID: 513321
    [No Abstract]   [Full Text] [Related]  

  • 28. [Determination of fibrinogen-fibrin degradation factors in neoplasms].
    Petrella V; Massara G; Parachini F; Silvera F; Cantone R
    Minerva Med; 1988 Feb; 79(2):117-21. PubMed ID: 3352945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Critical evaluation of new methods for studying fibrin degradation products].
    Prisco D
    Recenti Prog Med; 1989 May; 80(5):263-7. PubMed ID: 2669062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hypercoagulability and atherosclerosis (author's transl)].
    Tanaka K; Kanashiro M
    Rinsho Ketsueki; 1980 Jun; 21(6):745-50. PubMed ID: 7463734
    [No Abstract]   [Full Text] [Related]  

  • 31. [Urinary and serum fibrin/fibrinogen degradation products in renal transplant rejection (author's transl)].
    Akiyama T; Kaneko S; Iguchi M; Minami K; Kadowaki T
    Nihon Hinyokika Gakkai Zasshi; 1977 Jun; 68(6):599-608. PubMed ID: 335137
    [No Abstract]   [Full Text] [Related]  

  • 32. [Determination of coagulofibrinolytic factors by laser nephelometry (author's transl)].
    Nakamura K; Tokuda M; Iijima K
    Rinsho Byori; 1981; 29(7):655-61. PubMed ID: 7328798
    [No Abstract]   [Full Text] [Related]  

  • 33. [Application of gabexate mesilate on measurement of coagulation and fibrinolysis. --The effect of high molecular weight Fbg/Fb complex in plasma-- (author's transl)].
    Suzuki S; Tahara C; Kazama M
    Rinsho Byori; 1981 Apr; 29(4):404-8. PubMed ID: 6798246
    [No Abstract]   [Full Text] [Related]  

  • 34. Proteolytic degradation products from fibrinogen and fibrin with special respect to non-covalently associated complexes. Influence of fibrin crosslinking. Lysability and other properties.
    Feddersen C
    Scand J Clin Lab Invest Suppl; 1983; 166():1-60. PubMed ID: 6226084
    [No Abstract]   [Full Text] [Related]  

  • 35. Unreliability in the estimation of the molecular weight of fibrinogen degradation products (FDPs) by polyacrylamide/sodium dodecyl sulphate electrophoresis (SDS/PAGE).
    Arocha-Piñango CL; Perales J; Carvajal Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):737-41. PubMed ID: 2416650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy.
    von Tempelhoff GF; Nieman F; Heilmann L; Hommel G
    Clin Hemorheol Microcirc; 2000; 22(2):107-30. PubMed ID: 10831062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products].
    Dyr JE; Cajthamlová H; Suttnar J
    Cas Lek Cesk; 1990 Oct; 129(43):1349-51. PubMed ID: 2249231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Differentiation between fibrin degradation products and fibrinogen degradation products by using newly developed ELISAs].
    Isogai N; Yamagishi T; Kaku M; Matsumoto K; Yamamoto Y; Kuroso K; Arai M; Yorifuji H; Fukutake K; Fujimaki M
    Rinsho Byori; 1991 Jul; 39(7):753-7. PubMed ID: 1920869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinogen, fibrin(ogen) degradation products and fibrinopeptide A in pleural effusions. High turnover of fibrinogen in pleurisy.
    Widström O; Kockum C; Nilsson BS
    Scand J Respir Dis; 1978 Aug; 59(4):210-5. PubMed ID: 694476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of serum and synovial fluid fibrin degradation products (FDP) estimation in rheumatoid arthritis.
    Gulati PD; Sood KC; Saha K; Kumar A; Zizvi SN
    J Assoc Physicians India; 1982 Nov; 29(11):903-6. PubMed ID: 7130107
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.